Oxaliplatin 01
Oxaliplatin
Product Images NDC 79672-825
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 79672-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nextgen Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Oxaliplatin 02
Oxaliplatin 03
This text contains data related to DFS (disease-free survival) probability for different stages of treatment under FOLFOX4 and LVSFU2 for DUKES C cancer. It also shows the hazard ratio and Logrank test results for the disease. The numbers listed below the header "DFS (months)" show the duration of DFS for different treatment stages. Overall, this text is likely related to cancer research and treatment effectiveness.*
Oxaliplatin 04
This text is describing survival rates for two different drug combinations during a treatment period of 24 months. Patients who received Oxaliplatin Injection USP plus 5-FULV had a median survival time of 19.4 months, while those who received Oxaliplatin Injection USP plus irinotecan had a median survival time of 17.6 months. The percentage of patients surviving was analyzed using a log rank test, and the difference between the two drug combinations was statistically significant (p<0.0001).*
Oxaliplatin 05
This is a pharmaceutical product for intravenous use only. It contains Oxaliplatin as the active ingredient and lactose monohydrate as an excipient. It is available in 50 mg/vial dosage. The package insert contains instructions for reconstitution and further dilution of the drug. The product must be stored at 20°C-25°C and should not be reconstituted with sodium chloride/chloride-containing solutions. Unused portions should be discarded properly. No further information available.*
Oxaliplatin 06
The text appears to be a label for a drug. The drug is intended for intravenous use only and comes in a 50mg vial. The label also includes the manufacturer's product code. There is also a 2D barcode on the label.*
Oxaliplatin 07
This is a medication called Oxaliplatin, USP used for intravenous injection. The vial contains 100 mg of the medication and has to be reconstituted and diluted before use. Instructions for reconstitution and further dilution can be found in the package. The medication is a lyophilized powder, preservative-free and should not be reconstituted using sodium chloride. The medication should be stored at a controlled room temperature of 68°-77°F or 20°-25°C. Unused portions need to be discarded, and the medication is for single-use only.*
Oxaliplatin 08
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
